Harsing L G, Solyom S, Salamon C
EGIS Pharmaceuticals Ltd., Budapest, Hungary.
Neurochem Res. 2001 Sep;26(8-9):915-23. doi: 10.1023/a:1012328300037.
The effect of N-methyl-D-aspartic acid (NMDA), a selective glutamate receptor agonist, on the release of previously incorporated [3H]gamma-aminobutyric acid(GABA) was examined in superfused striatal slices of the rat. NMDA (0.01 to 1.0 mM) increased [3H]GABA overflow with an EC50 value of 0.09 mM. The [3H]GABA releasing effect of NMDA was an external Ca2+-dependent process and the GABA uptake inhibitor nipecotic acid (0.1 mM) potentiated this effect. These findings support the view that NMDA evokes GABA release from vesicular pool in striatal GABAergic neurons. Addition of glycine (1 mM), a cotransmitter for NMDA receptor, did not influence the NMDA-induced [3H]GABA overflow. Kynurenic acid (1 mM), an antagonist of glycineB site, decreased the [3H]GABA-releasing effect of NMDA and this reduction was suspended by addition of 1 mM glycine. Neither glycine nor kynurenic acid exerted effects on resting [3H]GABA outflow. These data suggest that glycineB binding site at NMDA receptor may be saturated by glycine released from neighboring cells. Glycyldodecylamide (GDA) and N-dodecylsarcosine, inhibitors of glycineT1 transporter, inhibited the uptake of [3H]glycine (IC50 33 and 16 microM) in synaptosomes prepared from rat hippocampus. When hippocampal slices were loaded with [3H]glycine, resting efflux was detected whereas electrical stimulation failed to evoke [3H]glycine overflow. Neither GDA (0.1 mM) nor N-dodecylsarcosine (0.3 mM) influenced [3H]glycine efflux. Using Krebs-bicarbonate buffer with reduced Na+ for superfusion of hippocampal slices produced an increased [3H]glycine outflow and electrical stimulation further enhanced this release. These experiments speak for glial and neuronal [3H]glycine release in hippocampus with a dominant role of the former one. GDA, however, did not influence resting or stimulated [3H]glycine efflux even when buffer with low Na+ concentration was applied.
在大鼠的脑纹状体切片中,研究了选择性谷氨酸受体激动剂N-甲基-D-天冬氨酸(NMDA)对先前掺入的[3H]γ-氨基丁酸(GABA)释放的影响。NMDA(0.01至1.0 mM)可增加[3H]GABA的溢出,其半数有效浓度(EC50)值为0.09 mM。NMDA的[3H]GABA释放效应是一个依赖细胞外Ca2+的过程,GABA摄取抑制剂尼克酸(0.1 mM)可增强此效应。这些发现支持以下观点:NMDA可诱发脑纹状体GABA能神经元囊泡池释放GABA。添加甘氨酸(1 mM)(NMDA受体的共递质)不会影响NMDA诱导的[3H]GABA溢出。甘氨酸B位点拮抗剂犬尿氨酸(1 mM)可降低NMDA的[3H]GABA释放效应,添加1 mM甘氨酸可消除这种降低。甘氨酸和犬尿氨酸对静息状态下的[3H]GABA流出均无影响。这些数据表明,NMDA受体上的甘氨酸B结合位点可能被相邻细胞释放的甘氨酸饱和。甘氨酰十二烷基酰胺(GDA)和N-十二烷基肌氨酸(甘氨酸T1转运体抑制剂)可抑制从大鼠海马体制备的突触体中[3H]甘氨酸的摄取(IC50分别为33和16 microM)。当海马体切片加载[3H]甘氨酸时,可检测到静息流出,但电刺激未能诱发[3H]甘氨酸溢出。GDA(0.1 mM)和N-十二烷基肌氨酸(0.3 mM)均不影响[3H]甘氨酸流出。使用降低Na+浓度的Krebs-碳酸氢盐缓冲液对海马体切片进行灌流,可使[3H]甘氨酸流出增加,电刺激可进一步增强这种释放。这些实验表明,海马体中存在胶质细胞和神经元释放[3H]甘氨酸的现象,且前者起主导作用。然而,即使使用低Na+浓度的缓冲液,GDA也不影响静息或刺激状态下的[3H]甘氨酸流出。